Thus, the hypothesis that MyD88-dependent signaling is required for EHO was tested in vitro and in vivo using global or Pdgfrα-conditional deletion of MyD88 in FOP mice. The gene discussed is PDGFRA; the disease is fibrodysplasia ossificans progressiva.